Gupta, R., Chaudhary, A. R., Shah, B. N., Jadhav, A. V., Zambad, S. P., Gupta, R. C., . . . Dutt, C. (2014). Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis. Dove Medical Press.
Citação norma ChicagoGupta, Ram, Anita R. Chaudhary, Binita N. Shah, Avinash V. Jadhav, Shitalkumar P. Zambad, Ramesh Chandra Gupta, Shailesh Deshpande, Vijay Chauthaiwale, and Chaitanya Dutt. Therapeutic Treatment With a Novel Hypoxia-inducible Factor Hydroxylase Inhibitor (TRC160334) Ameliorates Murine Colitis. Dove Medical Press, 2014.
Citação norma MLAGupta, Ram, et al. Therapeutic Treatment With a Novel Hypoxia-inducible Factor Hydroxylase Inhibitor (TRC160334) Ameliorates Murine Colitis. Dove Medical Press, 2014.